Request SampleGlobal Milk Thistle Extracts Sales Market Report 2023
SKU ID : QYR-22289320 | Publishing Date : 02-Jan-2023 | No. of pages : 117
Market Analysis and Insights: Global Milk Thistle Extracts Market
Milk Thistle is an herbal supplement that detoxifies and protects vital liver functions and more. Milk thistle has been used for over 2,000 years as a natural treatment for liver disorders. The plant is known in scientific circles as the Silybum marianum (L.) Gaertner (syn. Cardous marianus), but it is more commonly known as “milk thistle,” “St. Mary Thistle,” “Holy Thistle” and “Lady’s Thistle.” It is an herbaceous annual or biennial plant belonging to the Asteraceae family that can grow to be ten feet tall with flowers that are red and purple in color.
Due to the COVID-19 pandemic, the global Milk Thistle Extracts market size is estimated to be worth US$ 109 million in 2022 and is forecast to a readjusted size of US$ 166.9 million by 2029 with a CAGR of 6.2% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, >80% Extract accounting for % of the Milk Thistle Extracts global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.
Global Milk Thistle Extracts main players are Euromed, Panjin Tianyuan Pharmaceutical, Panjin Huacheng Pharmacy, Shengbo Silymarin, etc. Global top four manufacturers hold a share over 40%. China is the largest market, with a share nearly 55%.
Global Milk Thistle Extracts Scope and Market Size
The global Milk Thistle Extracts market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Milk Thistle Extracts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
>80% Extract
80% Extract
Low Concentration Product
Segment by Application
Pharmaceuticals
Health Care Industry
Food & Cosmetics
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Martin Bauer
Indena
Euromed
Panjin Tianyuan Pharmaceutical
Panjin Huacheng Pharmacy
Liverd Pharma
KEB Biotech
Shengbo Silymarin
Bio-Botanica
Milk Thistle is an herbal supplement that detoxifies and protects vital liver functions and more. Milk thistle has been used for over 2,000 years as a natural treatment for liver disorders. The plant is known in scientific circles as the Silybum marianum (L.) Gaertner (syn. Cardous marianus), but it is more commonly known as “milk thistle,” “St. Mary Thistle,” “Holy Thistle” and “Lady’s Thistle.” It is an herbaceous annual or biennial plant belonging to the Asteraceae family that can grow to be ten feet tall with flowers that are red and purple in color.
Due to the COVID-19 pandemic, the global Milk Thistle Extracts market size is estimated to be worth US$ 109 million in 2022 and is forecast to a readjusted size of US$ 166.9 million by 2029 with a CAGR of 6.2% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, >80% Extract accounting for % of the Milk Thistle Extracts global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Pharmaceuticals segment is altered to an % CAGR throughout this forecast period.
Global Milk Thistle Extracts main players are Euromed, Panjin Tianyuan Pharmaceutical, Panjin Huacheng Pharmacy, Shengbo Silymarin, etc. Global top four manufacturers hold a share over 40%. China is the largest market, with a share nearly 55%.
Global Milk Thistle Extracts Scope and Market Size
The global Milk Thistle Extracts market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Milk Thistle Extracts market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
>80% Extract
80% Extract
Low Concentration Product
Segment by Application
Pharmaceuticals
Health Care Industry
Food & Cosmetics
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Martin Bauer
Indena
Euromed
Panjin Tianyuan Pharmaceutical
Panjin Huacheng Pharmacy
Liverd Pharma
KEB Biotech
Shengbo Silymarin
Bio-Botanica
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
24/7 Research Support
Phone: +1 (888) 690-5999 
